研究显示,用于肥胖症和糖尿病的GLP-1药物可能会将重饮量削减近70%。 Study suggests GLP-1 drugs, used for obesity and diabetes, may cut heavy drinking by nearly 70%.

一项研究表明,用于肥胖症和糖尿病的GLP-1药物可能有助于重饮者将酒精消费量减少近70%。 A study shows that GLP-1 medications, used for obesity and diabetes, may help heavy drinkers reduce alcohol consumption by nearly 70%. 这些药物，如索马鲁肽和利拉鲁肽，也提供减肥和健康益处，但可能会引起恶心等副作用。 These drugs, like semaglutide and liraglutide, also offer weight loss and health benefits but may cause side effects such as nausea. GLP-1药物治疗酒精使用紊乱症的潜力大有希望,但还需要进一步研究。 The potential for GLP-1 drugs to treat alcohol use disorder is promising but requires further research.